LB enters its Q1 2026 earnings call — scheduled for May 7 — with short sellers at their most aggressive in over a month and the stock quietly 4.5% lower than it was 30 days ago.
Short interest is the clearest tension heading into the print. At 12.2% of the free float, it has climbed roughly 13% over the past month — the bulk of that move arriving in a single step around April 23-24, when positions jumped by more than 200,000 shares in one session. That puts the current short base at a 30-day high, even as the stock has pulled back from the mid-$70s in March. ORTEX's short score reflects the pressure: it has held above 73 for nearly two weeks, ranking in just the 3rd percentile of the broader universe — meaning the vast majority of stocks carry far less short-side conviction than LB. Days-to-cover of 9.4 amplifies the picture; unwinding this position quickly would not be easy.
The borrow market tells a more measured story. Cost to borrow has eased 13% over the week to 1.43% APR — comfortably low and well off the brief spike to 2.29% seen on May 1. Availability has loosened meaningfully from earlier in April, when the lending pool was tighter; with 68% of available shares currently lent out, there is still room for new shorts to establish positions without facing a squeeze in supply. The ORTEX availability rank sits in the 5th percentile, confirming the borrow market is tight relative to peers but not at a breaking point. Options traders are not sounding the alarm either: the put/call ratio of 0.71 is marginally below its 20-day average of 0.73, essentially neutral, and far from the 52-week high of 1.97 that marked peak defensiveness.
The Street remains broadly constructive but noticeably selective. The mean analyst price target of ~$80.57 implies roughly 22% upside from the current $66.14 close — a gap that has widened as the stock retreated from its March highs. The most recent analyst actions, from mid-March, were uniformly target-raising: Goldman Sachs lifted its buy-rated target from $69 to $84, and Wells Fargo raised its overweight target to $92. Barclays is the outlier, holding an equal-weight with a $75 target. Bulls point to the 9% sequential rise in produced water royalty volumes last quarter and the ~$20M EBITDA contribution expected from the 1918 Ranch acquisition this year. Bears flag the Permian Basin concentration risk, near-term EPS headwinds, and a premium valuation relative to peers — EV/EBITDA sits at 11.9x — that leaves little room for a miss. The EPS surprise factor score of 35 does not give confidence that beating expectations is habitual here.
Institutional ownership is highly concentrated, which matters for how any post-earnings move is absorbed. First Manhattan and Horizon Kinetics together hold nearly 45% of the company — both patient, long-duration holders. William Blair added roughly 692,000 shares in Q1 2026, the largest recent institutional accumulation in the top-holder list. That kind of buying from a growth-oriented manager stands in direct contrast to the rising short base, and sets up an unusual tug-of-war heading into the print. On the insider side, Director Chuck Watson sold roughly $3.97M of stock in early March at prices around $74-75, when the stock was trading well above current levels — not a panic sale, but worth noting given where the stock has since drifted.
Earnings history offers a mixed reference point. The February 2026 print produced a +13.8% single-day move and held its gains over five days. The March 19 event did the opposite — an 8.6% single-day decline that extended to -6.3% over the week. The pattern is binary rather than directional: this stock has moved sharply in both directions on recent results, which likely explains why the short base has grown ahead of tomorrow's call without options traders yet pricing in unusually large protection. The setup is one of elevated short conviction, loosening but still-tight borrow conditions, a wide price-target gap, and a binary earnings history — with the first confirmed Q1 2026 result due Thursday morning.
See the live data behind this article on ORTEX.
Open LB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
